Ocrelizumab is granted EU licence for primary progressive and relapsing remitting MS
The European Commission (EC) has granted a licence for the use of ocrelizumab, also known as Ocrevus, in people with primary progressive multiple sclerosis (PPMS) and relapsing remitting multiple sclerosis (RRMS)…Read more - http://www.ms-uk.org/ocrelizumab-grante ... mitting-ms
Ocrelizumab is granted EU licence for PPMS and RRMS
Ocrelizumab is granted EU licence for PPMS and RRMS
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 11253 Views
-
Last post by NHE
-
- 0 Replies
- 1051 Views
-
Last post by NHE
-
- 0 Replies
- 1660 Views
-
Last post by NHE
-
- 0 Replies
- 687 Views
-
Last post by DIM
-
- 0 Replies
- 2402 Views
-
Last post by NHE
-
- 1 Replies
- 1340 Views
-
Last post by vesta
-
- 0 Replies
- 1984 Views
-
Last post by frodo
-
- 0 Replies
- 1898 Views
-
Last post by NHE
-
- 0 Replies
- 1485 Views
-
Last post by NHE